{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T14:45:43Z","timestamp":1749480343557},"reference-count":34,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.vaccine.2003.09.042","type":"journal-article","created":{"date-parts":[[2004,2,5]],"date-time":"2004-02-05T10:35:33Z","timestamp":1075977333000},"page":"1564-1569","source":"Crossref","is-referenced-by-count":6,"title":["Recombinant meningococcal PorA protein, expressed using a vector system with potential for human vaccination, induces a bactericidal immune response"],"prefix":"10.1016","volume":"22","author":[{"given":"Holly E","family":"Humphries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette N","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E","family":"Heckels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.09.042_BIB1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","article-title":"Impact of meningococcal C conjugate vaccine in the UK","volume":"51","author":"Balmer","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB2","doi-asserted-by":"crossref","unstructured":"Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 1983;ii:355\u20137.","DOI":"10.1016\/S0140-6736(83)90340-9"},{"key":"10.1016\/j.vaccine.2003.09.042_BIB3","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/IAI.59.9.2963-2971.1991","article-title":"Topology of outer membrane porins in pathogenic Neisseria spp.","volume":"59","author":"van der Ley","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1099\/00222615-43-5-335","article-title":"Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease","volume":"43","author":"Idanpaan-Heikkila","year":"1995","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB5","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0264-410X(96)00001-1","article-title":"Phase-i clinical-trial with a hexavalent pora containing meningococcal outer-membrane vesicle vaccine","volume":"14","author":"Peeters","year":"1996","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2003.09.042_BIB7","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0264-410X(02)00546-7","article-title":"Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes","volume":"21","author":"Arigita","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.042_BIB8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/mpat.1996.0079","article-title":"Expression of Neisseria meningitidis class 1 porin as a fusion protein in Escherichia coli: the influence of liposomes and adjuvants on the production of a bactericidal immune response","volume":"21","author":"Ward","year":"1996","journal-title":"Microb. Pathol."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB9","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1099\/00221287-144-11-3027","article-title":"Immunisation with recombinant class 1 outer membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci","volume":"144","author":"Christodoulides","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2003.09.042_BIB10","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1128\/IAI.62.6.2432-2439.1994","article-title":"Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers","volume":"62","author":"Qi","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB11","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/IAI.69.6.3809-3816.2001","article-title":"Immunisation with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci","volume":"69","author":"Jolley","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB12","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunisation with recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0264-410X(95)00263-Z","article-title":"Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100","volume":"14","author":"Idanpaan-Heikkila","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.042_BIB14","doi-asserted-by":"crossref","unstructured":"Christodoulides M, Jolley K, Heckels JE. In: Pollard AJ, Maiden MCJ, editors. Meningococcal vaccines. Recombinant proteins in vaccine development. Totowa, NJ: Humana Press; 2001. p. 167\u201380.","DOI":"10.1385\/1-59259-148-5:167"},{"key":"10.1016\/j.vaccine.2003.09.042_BIB15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1046-5928(02)00534-X","article-title":"Expression of the Class 1 outer-membrane protein of Neisseria meningitidis in Escherichia coli and purification using a self-cleavable affinity tag","volume":"26","author":"Humphries","year":"2002","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB16","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.171.6.1871","article-title":"Deduced amino acid sequences of class 1 protein (porA) from 3 strains of Neisseria meningitidis: synthetic peptides define the epitopes responsible for serosubtype specificity","volume":"171","author":"McGuinness","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2958.1993.tb01141.x","article-title":"Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology","volume":"7","author":"McGuinness","year":"1993","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB18","unstructured":"Caugant DA, Wedege E, editors. Recombinant NspA incorporated into liposomal vesicles induces functional antibodies. Oslo, Norway: Norwegian Institute of Public Health; 2002. p. 134."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0140-6736(91)91297-8","article-title":"Point mutation in meningococcal porA gene associated with increased endemic disease","volume":"337","author":"McGuinness","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2003.09.042_BIB20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1099\/00221287-139-8-1729","article-title":"Immunisation with synthetic peptides containing epitopes of the class 1 outer membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunisation with a cyclic peptide","volume":"139","author":"Christodoulides","year":"1993","journal-title":"J. Gen. Microbiol."},{"issue":"7","key":"10.1016\/j.vaccine.2003.09.042_BIB21","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/IAI.64.7.2745-2751.1996","article-title":"Specificity of human bactericidal antibodies against PorA P1.7, 16 induced with a hexavalent meningococcal outer membrane vesicle vaccine","volume":"64","author":"van der Voort","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/IAI.51.2.571-578.1986","article-title":"Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting","volume":"51","author":"Wedege","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB23","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect. Immun."},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2003.09.042_BIB24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0264-410X(01)00371-1","article-title":"Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine","volume":"20","author":"de Kleijn","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.09.042_BIB25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/mpat.1995.0033","article-title":"Heterologous production of the P1 porin of Neisseria meningitidis in Bacillus subtilis: The effect of an N-terminal extension on the presentation of native-like epitopes","volume":"18","author":"Muttilainen","year":"1995","journal-title":"Microb. Pathol."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1574-695X.2000.tb01434.x","article-title":"Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis","volume":"27","author":"Jansen","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/infdis\/166.3.551","article-title":"Gonococcal porin vaccine evaluation: comparison of por proteosomes, liposomes, and blebs isolated from rmp deletion mutants","volume":"166","author":"Wetzler","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB28","unstructured":"Wetzler LM, Blake MS, Gotschlich EC. Protein-1 (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies. Trans Assoc Am Physicians 1989;102:78\u201390."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB29","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.09.042_BIB30","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/IAI.62.4.1437-1443.1994","article-title":"Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease","volume":"62","author":"Guttormsen","year":"1994","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.vaccine.2003.09.042_BIB31","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J. Exp. Med."},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2003.09.042_BIB32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-1656(00)00294-7","article-title":"Candidate Neisseria meningitidis NspA vaccine","volume":"83","author":"Martin","year":"2000","journal-title":"J. Biotechnol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.09.042_BIB33","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/IAI.69.3.1561-1567.2001","article-title":"Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection","volume":"69","author":"West","year":"2001","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.vaccine.2003.09.042_BIB34","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/IAI.63.3.884-890.1995","article-title":"Evaluation of transferrin binding protein 2 within the transferrin binding protein complex as a potential antigen for future meningococcal vaccines","volume":"63","author":"Lissolo","year":"1995","journal-title":"Infect. Immun."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T13:04:27Z","timestamp":1585573467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":34,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0264410X04000416"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.09.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}